EGFR and squamous cell carcinoma: In addition, it has been demonstrated to perturb tumor angiogenesis [74], to elicit apoptosis in a squamous cell carcinoma model [75], to induce mitophagy [76] and to confine the metastatic spreading of breast carcinoma cells through the down-regulation of EGFR activity [30,77].